Weight-loss drug cuts knee osteoarthritis pain in 1,000+ patient trial
Published 2 d ago2 sourcesEvidence: Reported
An expert suggests GLP-1 weight-loss medications, currently approved for teenagers, could be offered to obese pre-schoolers as young as three within two years. This signals a potential major expansion of pediatric obesity treatment, though regulatory approval and clinical evidence for this age group remain uncertain.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 6 h ago1 sourceEvidence: Reported
Published 7 h ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported